Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julie M Curtsinger

Showing results (21-30 of 24) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 24 results.
Blood Advances|July 4, 2019
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemiaSarah Cooley, Fiona He, Veronika Bachanova, et al.
Blood|November 15, 2011
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytesKeli L Hippen, Christoph Bucher, Dawn K Schirm, et al.
Cytotherapy|November 27, 2016
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trialsDavid H McKenna, Darin Sumstad, Diane M Kadidlo, et al.
Immunity|July 23, 2013
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunityYaya Wang, Iftach Shaked, Stephanie M Stanford, et al.
Pageof 3

Showing results (21-30 of 24) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 24 results.
Blood Advances|July 4, 2019
First-in-human trial of rhIL-15 and haploidentical natural killer cell therapy for advanced acute myeloid leukemiaSarah Cooley, Fiona He, Veronika Bachanova, et al.
Blood|November 15, 2011
Blocking IL-21 signaling ameliorates xenogeneic GVHD induced by human lymphocytesKeli L Hippen, Christoph Bucher, Dawn K Schirm, et al.
Cytotherapy|November 27, 2016
Optimization of cGMP purification and expansion of umbilical cord blood-derived T-regulatory cells in support of first-in-human clinical trialsDavid H McKenna, Darin Sumstad, Diane M Kadidlo, et al.
Immunity|July 23, 2013
The autoimmunity-associated gene PTPN22 potentiates toll-like receptor-driven, type 1 interferon-dependent immunityYaya Wang, Iftach Shaked, Stephanie M Stanford, et al.
Pageof 3